PD05-03 EFFICACY AND SAFETY OF LUMASIRAN IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1: 24-MONTH ANALYSIS OF THE ILLUMINATE-A TRIAL. (May 2022) - Lieske, John; Groothoff, Jaap; Frishberg, Yaacov; Sellier-Leclerc, Anne-Laure; Shasha-Lavsky, Hadas; Saland, Jeffrey; Hayes, Wesley; Magen, Daniella; Moochhala, Shabbir; Coenen, Martin; Simkova, Eva; Ngo, Taylor; et al.